Search All News
A new program at Columbia is looking for earlier signs of ALS so that future treatments can be delivered before extensive neurological damage occurs.
Columbia neurologists found that a test used to measure Alzheimer's disease proteins in spinal fluid can be used to determine whether patients have the disease or other forms of dementia.
- November 8, 2017
New Zika research from Columbia University suggests that high rates of microcephaly in Brazil were not caused by new mutations in the virus, as previously believed.
- October 3, 2017
Scientists propose a new model for Alzheimer's disease that may explain the high failure rate of recent clinical trials.
- September 18, 2017
A cellular defense against protein aggregates suppresses ALS in early stages but later hastens spread of the disease, a study in mice suggests.
- September 1, 2017
With miniature mobile microscopes, Columbia neuroscientists have uncovered a map deep in the brain that guides movement in mice.
- August 29, 2017
Age-related memory loss was reversed by boosting blood levels of osteocalcin, a hormone produced by bone cells, in mice.
- July 26, 2017
Columbia neurologist Denise Chou, MD, explains a new breakthrough in headache medicine: the first targeted preventive therapy for migraine.
- July 17, 2017
A new study suggests how nutrients found in brain-healthy foods can reduce inflammation and lower Alzheimer's risk.
- June 21, 2017
Researchers have found the first direct evidence that autoimmunity plays a role in Parkinson’s disease.
- May 25, 2017
Certain women with preeclampsia are more likely to have a pregnancy-related stroke, finds a new study led by Columbia neurologists.